A new horizon for the treatment of heparin-induced thrombocytopenia?
Abrams
Charles S
CS
Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. abrams@mail.med.upenn.edu
D000925:Anticoagulants / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*
D000925:Anticoagulants; D006493:Heparin